Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, et al. Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider. J Am Heart Assoc. 2022;11:e025784.
Article PubMed PubMed Central Google Scholar
Semberova J, Sirc J, Miletin J, Kucera J, Berka I, Sebkova S, et al. Spontaneous closure of patent ductus arteriosus in infants ≤1500 g. Pediatrics. 2017;140:e20164258.
Benitz WE. Committee on Fetus and Newborn, American Academy of Pediatrics. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137. https://doi.org/10.1542/peds.2015-3730.
Nelson RJ, Thibeault DW, Emmanouilides GC, Lippmann M. Improving the results of ligation of patent ductus arteriosus in small preterm infants. J Thorac Cardiovasc Surg. 1976;71:169–78.
Article CAS PubMed Google Scholar
Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011;128:e1618–e1621.
Manalastas M, Zaheer F, Nicoski P, Weiss MG, Amin S. Acetaminophen therapy for persistent patent ductus arteriosus. NeoReviews. 2021;22:e320–e331.
Stark A, Smith PB, Hornik CP, Zimmerman KO, Hornik CD, Pradeep S, et al. Medication use in the neonatal intensive care unit and changes from 2010 to 2018. J Pediatr. 2022;240:66–71.e4.
Al-Turkait A, Szatkowski L, Choonara I, Ojha S. Drug utilisation in neonatal units in England and Wales: a national cohort study. Eur J Clin Pharm. 2022;78:669–77.
Gouyon B, Martin-Mons S, Iacobelli S, Razafimahefa H, Kermorvant-Duchemin E, Brat R, et al. Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-8). An inventory for future research. PLOS One. 2019;14:e0222667.
Article CAS PubMed PubMed Central Google Scholar
Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Håkansson S, Lindqvist J, et al. Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320). J Perinatol. 2019;39:599–607.
Article PubMed PubMed Central Google Scholar
Dani C, Mosca F, Cresi F, Lago P, Lista G, Laforgia N, et al. Patent ductus arteriosus in preterm infants born at 23–24 weeks’ gestation: Should we pay more attention? Early Hum Dev. 2019;135:16–22.
Mukherjee A, Jadhav V, Gupta A. Off-label use of paracetamol in managing patent ductus arteriosus across neonatal intensive care units in the UK. Arch Dis Child Fetal Neonatal Ed. 2021;106:113–4.
Dowd LA, Wheeler BJ, Al-Sallami HS, Broadbent RS, Edmonds LK, Medlicott NJ. Paracetamol treatment for patent ductus arteriosus: practice and attitudes in Australia and New Zealand. J Matern Fetal Neonatal Med. 2019;32:3039–44.
Article CAS PubMed Google Scholar
Jasani B, Mitra S, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2022, https://doi.org/10.1002/14651858.CD010061.pub5.
Jasani B, Weisz DE, McNamara PJ. Evidence-based use of acetaminophen for hemodynamically significant ductus arteriosus in preterm infants. Semin Perinatol. 2018;42:243–52.
Article CAS PubMed Google Scholar
Squires RH. Acute liver failure in children. Semin Liver Dis. 2008;28:153–66.
Article CAS PubMed Google Scholar
Lee WS, McKiernan P, Kelly DA. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United Kingdom. J Pediatr Gastroenterol Nutr. 2005;40:575–81.
Squires RH, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652–658.e2.
Article PubMed PubMed Central Google Scholar
Wright CJ. Acetaminophen and the developing lung: could there be lifelong consequences? J Pediatr. 2021;235:264–276.e1.
Article CAS PubMed PubMed Central Google Scholar
McCulley DJ, Jensen EA, Sucre JMS, McKenna S, Sherlock LG, Dobrinskikh E, et al. Racing against time: leveraging preclinical models to understand pulmonary susceptibility to perinatal acetaminophen exposures. Am J Physiol Lung Cell Mol Physiol. 2022;323:L1–L13.
Article CAS PubMed Google Scholar
Pacifici GM, Allegaert K. Clinical pharmacology of paracetamol in neonates: a review. Curr Ther Res. 2015;77:24–30.
Article CAS PubMed Google Scholar
McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 2013;30:2174–87.
Article CAS PubMed PubMed Central Google Scholar
Ramachandran A, Jaeschke H. Acetaminophen toxicity: novel insights into mechanisms and future perspectives. Gene Expr. 2018;18:19–30.
Article CAS PubMed PubMed Central Google Scholar
Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol. 2016;4:131–42.
PubMed PubMed Central Google Scholar
Sandoval J, Orlicky DJ, Allawzi A, Butler B, Ju C, Phan CT, et al. Toxic acetaminophen exposure induces distal lung ER stress, proinflammatory signaling, and emphysematous changes in the adult murine lung. Oxid Med Cell Longev. 2019;2019:1–15.
Lee WM. Acetaminophen (APAP) hepatotoxicity—Isn’t it time for APAP to go away? J Hepatol. 2017;67:1324–31.
Article CAS PubMed PubMed Central Google Scholar
Robinson JF, Hamilton EG, Lam J, Chen H, Woodruff TJ. Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues. Placenta. 2020;100:35–44.
Article CAS PubMed PubMed Central Google Scholar
Sadler NC, Nandhikonda P, Webb-Robertson B-J, Ansong C, Anderson LN, Smith JN, et al. Hepatic cytochrome p450 activity, abundance, and expression throughout human development. Drug Metab Dispos. 2016;44:984–91.
Article CAS PubMed PubMed Central Google Scholar
Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharm Ther. 2008;118:250–67.
Hart SN, Cui Y, Klaassen CD, Zhong X. Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab Dispos. 2009;37:116–21.
Article CAS PubMed Google Scholar
Xu S-F, Hu A-L, Xie L, Liu J-J, Wu Q, Liu J. Age-associated changes of cytochrome P450 and related phase-2 gene/proteins in livers of rats. PeerJ. 2019;7:e7429.
Article PubMed PubMed Central Google Scholar
Green MD, Shires TK, Fischer LJ. Hepatotoxicity of acetaminophen in neonatal and young rats. I. Age-related changes in susceptibility. Toxicol Appl Pharm. 1984;74:116–24.
Hart JG, Timbrell JA. The effect of age on paracetamol hepatotoxicity in mice. Biochem Pharm. 1979;28:3015–7.
Article CAS PubMed Google Scholar
Oesch F, Fabian E, Landsiedel R. Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models. Arch Toxicol. 2019;93:3419–89.
Article CAS PubMed Google Scholar
Hukkanen J, Pelkonen O, Hakkola J, Raunio H. Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol. 2002;32:391–411.
Article CAS PubMed Google Scholar
Hart SG, Cartun RW, Wyand DS, Khairallah EA, Cohen SD. Immunohistochemical localization of acetaminophen in target tissues of the CD-1 mouse: correspondence of covalent binding with toxicity. Fundam Appl Toxicol J Soc Toxicol. 1995;24:260–74.
Placke ME, Wyand DS, Cohen SD. Extrahepatic lesions induced by acetaminophen in the mouse. Toxicol Pathol. 1987;15:381–7.
Article CAS PubMed Google Scholar
Jeffery EH, Haschek WM. Protection by dimethylsulfoxide against acetaminophen-induced hepatic, but not respiratory toxicity in the mouse. Toxicol Appl Pharm. 1988;93:452–61.
Gu J, Cui H, Behr M, Zhang L, Zhang Q-Y, Yang W, et al. In vivo mechanisms of tissue-selective drug toxicity: effects of liver-specific knockout of the NADPH-cytochrome P450 reductase gene on acetaminophen toxicity in kidney, lung, and nasal mucosa. Mol Pharm. 2005;67:623–30.
留言 (0)